361 related articles for article (PubMed ID: 28327605)
1. Ginsenoside Rb1 protects against ischemia/reperfusion-induced myocardial injury via energy metabolism regulation mediated by RhoA signaling pathway.
Cui YC; Pan CS; Yan L; Li L; Hu BH; Chang X; Liu YY; Fan JY; Sun K; -Li Q; Han JY
Sci Rep; 2017 Mar; 7():44579. PubMed ID: 28327605
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK.
Li G; Qian W; Zhao C
Can J Physiol Pharmacol; 2016 Jan; 94(1):97-103. PubMed ID: 26550918
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats.
Wu Y; Xia ZY; Dou J; Zhang L; Xu JJ; Zhao B; Lei S; Liu HM
Mol Biol Rep; 2011 Oct; 38(7):4327-35. PubMed ID: 21113666
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.
Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F
PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia reperfusion injury through mTOR signal pathway.
Li CY; Yang P; Jiang YL; Lin Z; Pu YW; Xie LQ; Sun L; Lu D
Biomed Pharmacother; 2020 May; 125():109913. PubMed ID: 32006902
[TBL] [Abstract][Full Text] [Related]
6. Oxycodone inhibits myocardial cell apoptosis after myocardial ischemia-reperfusion injury in rats via RhoA/ROCK1 signaling pathway.
Xie Y; Ge CL; Zhang ZY; Fei GX
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6371-6379. PubMed ID: 32572934
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B.
Yang L; Zhang Y; Zhu M; Zhang Q; Wang X; Wang Y; Zhang J; Li J; Yang L; Liu J; Liu F; Yang Y; Kang L; Shen Y; Qi Z
Free Radic Biol Med; 2016 Dec; 101():1-9. PubMed ID: 27667182
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I.
Jiang L; Yin X; Chen YH; Chen Y; Jiang W; Zheng H; Huang FQ; Liu B; Zhou W; Qi LW; Li J
Theranostics; 2021; 11(4):1703-1720. PubMed ID: 33408776
[No Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
Chen XG; Lv YX; Zhao D; Zhang L; Zheng F; Yang JY; Li XL; Wang L; Guo LY; Pan YM; Yan YW; Chen SY; Wang JN; Tang JM; Wan Y
Mol Cell Biochem; 2016 Feb; 413(1-2):9-23. PubMed ID: 26769665
[TBL] [Abstract][Full Text] [Related]
11. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.
Wang Z; Wang Z; Wang T; Yuan J; Wang X; Zhang Z
Rev Cardiovasc Med; 2019 Sep; 20(3):187-197. PubMed ID: 31601093
[TBL] [Abstract][Full Text] [Related]
13. ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury.
He K; Yan L; Pan CS; Liu YY; Cui YC; Hu BH; Chang X; Li Q; Sun K; Mao XW; Fan JY; Han JY
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1764-76. PubMed ID: 25305180
[TBL] [Abstract][Full Text] [Related]
14. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction.
Wang Z; Li M; Wu WK; Tan HM; Geng DF
Cardiovasc Drugs Ther; 2008 Dec; 22(6):443-52. PubMed ID: 18679782
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B‑cell lymphoma/B‑cell lymphoma‑associated X protein pathway.
Wang Y; Hu Z; Sun B; Xu J; Jiang J; Luo M
Mol Med Rep; 2015 Jun; 11(6):4518-24. PubMed ID: 25672441
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
19. Insulin/NFκB protects against ischemia-induced necrotic cardiomyocyte death.
Díaz A; Humeres C; González V; Gómez MT; Montt N; Sanchez G; Chiong M; García L
Biochem Biophys Res Commun; 2015 Nov; 467(2):451-7. PubMed ID: 26449460
[TBL] [Abstract][Full Text] [Related]
20. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
